ARDS logo

Aridis Pharmaceuticals, Inc. (ARDS)

Profile

Full Name

Aridis Pharmaceuticals, Inc.

Ticker

NASDAQ: ARDS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 14, 2018

Indexes

Not included

Website

http://www.aridispharma.com

Employees

37

Key Details

Price

$0.00(0.00%)

Market cap

$4457.40(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.62(+57.03% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.00
    ARDS price is $0.00

    30-Day Relative Volume

    0.00
    ARDS 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    ARDS price has remained unchanged on Jul 25, 2025

    Price YTD change

    0%
    ARDS price has remained unchanged since January 1st

    Price 1-year change

    -90%
    ARDS price is down -90% year-on-year

    Price 3-year change

    -99.99%
    ARDS price is down -99.99% over the past 3 years

    Price Range

    Price All-time high

    $13.85
    ARDS price is currently -100.00% below its historical high of $13.85

    Price 3-year low

    $0.00
    ARDS price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4457.40
    ARDS market capitalization is $4457.40

    Market cap 3-year change

    -99.98%
    ARDS market capitalization is down -99.98% over the past 3 years

    Market cap All-time high

    $110.89M
    ARDS market capitalization is currently -100.00% below its historical high of $110.89 million

    Market cap sector rank

    1.15%
    ARDS market capitalization is higher than 1.15% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    ARDS shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +151.81%
    ARDS shares outstanding is up +151.81% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    ARDS beta is 0.61

    200-day SMA

    $0.00
    ARDS price is currently equal to its 200-day simple moving average

    50-day SMA

    $0.00
    ARDS price is currently equal to its 50-day simple moving average

    RSI

    50.00
    ARDS 14-day relative strength index is 50.00

    Volume

    0.00
    ARDS 30-day relative volume is 0.00

    ATR

    $0.00
    ARDS average true range is $0.00

    10-day Historical Volatility

    0.00%
    ARDS 10-day historical volatility is 0.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ARDS annual revenue value is unknown

    Revenue Analysts estimate

    $21.40M
    ARDS annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    ARDS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ARDS annual revenue is unknown

    EPS

    EPS

    -$1.62
    ARDS annual earnings per share is -$1.62

    EPS Analysts estimate

    -
    ARDS annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +57.03%
    ARDS annual earnings per share is up +57.03% year-on-year

    EPS Sector rank

    43.73%
    ARDS annual earnings per share is higher than 43.73% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ARDS annual gross profit value is unknown

    Gross margin

    -
    ARDS annual gross profit margin value is unknown

    Operating profit

    -$29.99M
    ARDS annual operating income is -$29.99 million

    Operating margin

    -
    ARDS annual operating profit margin value is unknown

    Net income

    -$30.37M
    ARDS annual net profit is -$30.37 million

    Net margin

    -
    ARDS annual net profit margin value is unknown

    Expenses

    Total expenses

    $29.99M
    ARDS annual total expenses is $29.99 million

    Operating expenses

    $29.99M
    ARDS annual total operating expenses is $29.99 million

    Cost of goods sold

    -
    ARDS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $7.16M
    ARDS annual SGA is $7.16 million

    Depreciation and amortization

    $487.00K
    ARDS annual depreciation & amortization is $487.00 thousand

    Interest expense

    -
    ARDS annual interest expense value is unknown

    Income tax

    -
    ARDS annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$29.99M
    ARDS annual earnings before interest & taxes is -$29.99 million

    EBITDA

    -$29.51M
    ARDS annual EBITDA is -$29.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $14.70M
    ARDS annual total assets is $14.70 million

    Non current assets

    $3.07M
    ARDS annual long term assets is $3.07 million

    Current assets

    $11.63M
    ARDS annual total current assets is $11.63 million

    Cash and cash equivalents

    $4.88M
    ARDS annual cash & cash equivalents is $4.88 million

    Accounts receivable

    $1.00M
    ARDS annual accounts receivable is $1.00 million

    Inventory

    -
    ARDS annual inventory value is unknown

    Liabilities

    Total liabilities

    $38.93M
    ARDS annual total liabilities is $38.93 million

    Long term liabilities

    $2.03M
    ARDS annual total long term liabilities is $2.03 million

    Current liabilities

    $36.90M
    ARDS annual total current liabilities is $36.90 million

    Accounts payable

    $2.31M
    ARDS annual accounts payable is $2.31 million

    Debt

    Total debt

    $6.13M
    ARDS annual total debt is $6.13 million

    Total debt 1-year change

    +2.54%
    ARDS annual total debt is up +2.54% year-on-year

    Long term debt

    $1.29M
    ARDS annual long term debt is $1.29 million

    Short term debt

    $4.84M
    ARDS annual short term debt is $4.84 million

    Equity & Capital

    Shareholders equity

    -$24.23M
    ARDS annual stockholders equity is -$24.23 million

    Book value

    -$24.23M
    ARDS annual book value is -$24.23 million

    Retained earnings

    -$195.67M
    ARDS annual retained earnings is -$195.67 million

    Working capital

    -$25.27M
    ARDS annual working capital is -$25.27 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$29.13M
    ARDS annual cash flow from operations is -$29.13 million

    Cash from operations 1-year change

    -26.99%
    ARDS annual cash flow from operations is down -26.99% year-on-year

    Cash from investing

    -$82.00K
    ARDS annual cash flow from investing activities is -$82.00 thousand

    Cash from investing 1-year change

    +84.53%
    ARDS annual cash flow from investing activities is up +84.53% year-on-year

    Cash from financing

    $14.78M
    ARDS annual cash flow from financing activities is $14.78 million

    Cash from financing 1-year change

    -57.43%
    ARDS annual cash flow from financing activities is down -57.43% year-on-year

    CAPEX

    CAPEX

    -
    ARDS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ARDS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$29.21M
    ARDS annual free cash flow is -$29.21 million

    Free cash flow 1-year change

    -24.47%
    ARDS annual free cash flow is down -24.47% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ARDS annual gross profit margin value is unknown

    Operating margin

    -
    ARDS annual operating profit margin value is unknown

    Net margin

    -
    ARDS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -206.68%
    ARDS annual return on assets is -206.68%

    ROE

    125.33%
    ARDS annual return on equity is 125.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ARDS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ARDS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.00
    ARDS price to book ratio is 0.00

    PB ratio Sector rank

    16.54%
    ARDS price to book ratio is higher than 16.54% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ARDS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ARDS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.81M
    ARDS enterprise value is $4.81 million

    Enterprise value Sector rank

    16.01%
    ARDS enterprise value is higher than 16.01% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.60
    ARDS EV/EBITDA is -7.60

    EV/EBITDA Sector rank

    18.31%
    ARDS EV/EBITDA is higher than 18.31% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.32
    ARDS annual current ratio is 0.32

    Quick ratio

    -
    ARDS annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.25
    ARDS annual debt to equity ratio is -0.25

    Interest coverage ratio

    -
    ARDS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ARDS piotroski f-score value is unknown

    Altman Z-Score

    -
    ARDS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Nov 6, 23 HC Wainwright & Co.
    Buy
    Oct 20, 23 HC Wainwright & Co.
    Buy
    Jan 26, 23 HC Wainwright & Co.
    Buy
    Aug 16, 22 Maxim Group
    Hold
    Jul 20, 21 HC Wainwright & Co.
    Buy
    May 15, 20 HC Wainwright & Co.
    Buy
    May 15, 20 H.C. Wainwright
    Buy
    Feb 19, 20 Roth Capital
    Buy
    Dec 30, 19 HC Wainwright & Co.
    Buy
    Dec 30, 19 H.C. Wainwright
    Buy

    Institutional Ownership

    Screeners with ARDS included

    Stocks cheaper than 1 dollar
    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Aridis Pharmaceuticals, Inc.?
    • Does Aridis Pharmaceuticals, Inc. pay dividends?
    • What sector is Aridis Pharmaceuticals, Inc. in?
    • What industry is Aridis Pharmaceuticals, Inc. in?
    • What country is Aridis Pharmaceuticals, Inc. based in?
    • When did Aridis Pharmaceuticals, Inc. go public?
    • Is Aridis Pharmaceuticals, Inc. in the S&P 500?
    • Is Aridis Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Aridis Pharmaceuticals, Inc. in the Dow Jones?
    • When was Aridis Pharmaceuticals, Inc.'s last earnings report?
    • When does Aridis Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Aridis Pharmaceuticals, Inc.?

    The ticker symbol for Aridis Pharmaceuticals, Inc. is NASDAQ:ARDS

    Does Aridis Pharmaceuticals, Inc. pay dividends?

    No, Aridis Pharmaceuticals, Inc. does not pay dividends

    What sector is Aridis Pharmaceuticals, Inc. in?

    Aridis Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Aridis Pharmaceuticals, Inc. in?

    Aridis Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Aridis Pharmaceuticals, Inc. based in?

    Aridis Pharmaceuticals, Inc. is headquartered in United States

    When did Aridis Pharmaceuticals, Inc. go public?

    Aridis Pharmaceuticals, Inc.'s initial public offering (IPO) was on August 14, 2018

    Is Aridis Pharmaceuticals, Inc. in the S&P 500?

    No, Aridis Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Aridis Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Aridis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Aridis Pharmaceuticals, Inc. in the Dow Jones?

    No, Aridis Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Aridis Pharmaceuticals, Inc.'s last earnings report?

    Aridis Pharmaceuticals, Inc.'s most recent earnings report was on November 6, 2023

    When does Aridis Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Aridis Pharmaceuticals, Inc. is August 6, 2025
    On this page